|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.30 USD | +0.02% |
|
+3.04% | +23.77% |
| Market Cap | 9.88B 8.58B 7.97B 7.35B 13.84B 943B 14.1B 94.35B 36.94B 468B 37.1B 36.29B 1,575B | P/E 2026 * |
12.5x | P/E 2027 * | 9.59x |
|---|---|---|---|---|---|
| Enterprise Value | 11.2B 9.73B 9.04B 8.33B 15.7B 1,070B 15.98B 107B 41.89B 531B 42.07B 41.15B 1,786B | EV / Sales 2026 * |
6.34x | EV / Sales 2027 * | 5.03x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | +0.02% | ||
| 1 week | +3.04% | ||
| Current month | +6.43% | ||
| 1 month | +6.43% | ||
| 3 months | +30.85% | ||
| 6 months | +16.16% | ||
| Current year | +23.77% |
| 1 week | 81.21 |  | 84.44 |
| 1 month | 73.89 | | 84.44 |
| Current year | 61.32 | | 84.44 |
| 1 year | 58.53 | | 84.44 |
| 3 years | 32.83 | | 84.44 |
| 5 years | 29.85 | | 84.44 |
| 10 years | 8.18 | | 84.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
| Director of Finance/CFO | - | 2026-06-07 | |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.02% | +3.04% | +38.65% | +90.79% | 9.88B | |
| -0.44% | -0.53% | +58.76% | +22.05% | 321B | |
| +1.70% | +4.31% | +31.60% | -9.17% | 71.5B | |
| -3.60% | -2.43% | -1.64% | -5.95% | 8.7B | |
| +2.65% | +1.04% | -23.09% | -5.02% | 4.25B | |
| +5.26% | +5.41% | -38.54% | +12.12% | 3.86B | |
| -3.86% | -8.18% | -12.14% | -2.26% | 3.47B | |
| -2.06% | -3.35% | +35.91% | +49.93% | 2.65B | |
| -0.68% | +4.52% | -4.75% | -5.33% | 2.23B | |
| -5.33% | -12.77% | -32.37% | +13.32% | 1.7B | |
| Average | -0.64% | +1.03% | +5.24% | +16.05% | 42.88B | |
| Weighted average by Cap. | -0.12% | +4.42% | +49.45% | +17.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.54B 1.43B 1.31B 2.48B 169B 2.52B 16.88B 6.61B 83.81B 6.64B 6.49B 282B | 2B 1.74B 1.62B 1.49B 2.81B 191B 2.86B 19.14B 7.49B 95.04B 7.53B 7.36B 320B |
| Net income | 812M 705M 655M 604M 1.14B 77.53B 1.16B 7.75B 3.04B 38.5B 3.05B 2.98B 129B | 1.03B 898M 834M 769M 1.45B 98.73B 1.48B 9.88B 3.87B 49.04B 3.88B 3.8B 165B |
| Net Debt | 1.32B 1.15B 1.07B 984M 1.85B 126B 1.89B 12.63B 4.94B 62.7B 4.97B 4.86B 211B | 205M 178M 165M 152M 287M 19.56B 292M 1.96B 766M 9.71B 769M 752M 32.67B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$83.30 | +0.02% | 2,135,849 |
| 26-07-29 | US$83.28 | -0.20% | 1,634,260 |
| 26-07-28 | US$83.45 | +2.41% | 2,623,608 |
| 26-07-27 | US$81.48 | -0.55% | 1,435,892 |
| 26-07-24 | US$81.93 | +1.35% | 1,661,209 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
